SectorBiological Technology
Established Date26/07/2006
Listing Date24/02/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees22
Fiscal Year Ends31/07
Security TypeCommon stock
Office addressSuite 300 - 235 15th Street, West Vancouver, BC V7T 2X1
Business
IntroductionBriaCell Therapeutics Corp. was founded in British Columbia on July 26, 2006. The company is a clinical-stage biotechnology company that is developing new immunotherapies to transform cancer treatment. Immunotherapies are at the forefront of the fight against cancer because they use the body's own immune system to identify and destroy cancer cells. The company is currently advancing a pivotal Phase 1 Phase 3 study of its Bria-IMT targeted immunotherapy in combination with immune checkpoint inhibitors for advanced metastatic breast cancer.
